NCT06935552

Ketamine and Lidocaine Infusion in Refractory Chronic Migraine

Ketamine and Lidocaine Infusion for Refractory Chronic Migraine: Comparative Study

• Status: Not Yet Recruiting
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 44 (estimated)
• Sponsor: Assiut University · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: —

Summary

Ketamine and lidocaine infusion for refractory chronic migraine: Comparative Study

Conditions

• Refractory Chronic Migraine

Interventions

Type	Name	Description
DRUG	Ketamine infusion	group A will receive ketamine intravenous infusion
DRUG	Lidocaine Intravenous Infusion	group B will receive lidocaine intravenous infusion
DRUG	Dextrose 5% in water	group C will only receive Dextrose 5% in water

Timeline

• Start date: 2025-06-01
• Primary completion: 2026-11-01
• Completion: 2026-12-01
• First posted: 2025-04-20
• Last updated: 2025-04-20